Leerink Partners senior managing director David Risinger (Cellarity)

‘This is self-in­flict­ed’: Leerink’s David Risinger on the mar­ket shock and hits to bio­phar­ma

As the mar­kets con­tin­ued to fall Mon­day in re­sponse to the Trump ad­min­is­tra­tion’s tar­iff pro­pos­als, biotech has par­tic­u­lar­ly been hit hard. The …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.